EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advances in Liposomal Drug Delivery Systems

Dr. Lucia Fernandez,

American Journal Of Pharmacy And Pharmacology · 28.02.2025 · 6 (1) · 17-29

DOI: 10.71465/ajpp.3368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 28.02.2025. Verfasst von Dr. Lucia Fernandez,. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomal drug delivery systems (LDDS) have revolutionized pharmaceutical therapy by enhancing the therapeutic index of drugs through improved pharmacokinetics and targeted delivery. These nanocarriers offer a biocompatible, versatile platform to encapsulate a wide range of bioactive compounds, reducing toxicity and improving bioavailability. Advances in liposomal formulation, including PEGylation, ligand targeting, and stimuli-responsive systems, have further expanded their clinical utility. This review provides a comprehensive overview of modern liposomal technologies and their implications in drug delivery.

Zitieren

APA

Fernandez,, D. L. (2025). Advances in Liposomal Drug Delivery Systems. American Journal Of Pharmacy And Pharmacology, 6(1), 17-29. https://doi.org/10.71465/ajpp.3368

Vancouver

Fernandez, DL. Advances in Liposomal Drug Delivery Systems. American Journal Of Pharmacy And Pharmacology. 2025;6(1):17-29. doi:10.71465/ajpp.3368

BibTeX
@article{Fernandez2025,
  author = {Fernandez,, Dr. Lucia},
  title = {Advances in Liposomal Drug Delivery Systems},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2025},
  volume = {6},
  number = {1},
  pages = {17--29},
  doi = {10.71465/ajpp.3368}
}
Kostenlos starten →